Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9567 versus prednisolone in active rheumatoid arthritis
2017-000838-64Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mizacorat in rheumatoid arthritis (RA) (2 arms), sponsored by AstraZeneca. Primary endpoint: Change from baseline in 28-joint Disease Activity Score using C-reactive protein. Started Jun 2017; status: terminated.
02
Drugs
mizacorat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2017-000838-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000838-64.